Executive answer
“Contract manufacturer” and “limited-risk distributor” are useful descriptions only when agreements, people, assets, decisions and outcomes support them. An entity selecting vendors, deciding capacity, developing processes, pricing products, controlling inventory or absorbing persistent losses may perform more than routine functions despite contractual language.
Validation reconstructs actual operations, maps risk control, tests financial capacity, reviews remuneration and proves policy execution during the year. The objective is not a convenient label, but delineated transactions and appropriate returns for contributions.
Research and verification cutoff: August 2, 2026. This material is informational and does not replace a company-specific functional analysis.
The label is not the analysis
Labels summarize a model but do not establish facts. Contract manufacturers can differ in inventory, technology, capacity, quality and warranty. Limited-risk distributors can hold very different commercial authority.
Define what the label means for the group through a matrix rather than generic language copied from a global agreement.
Contract manufacturer
In a typical model, the entity produces to affiliate specifications, receives materials or buys under instructions and earns a cost-based return. Still identify who decides volume, inputs, process, investment, quality, inventory and capacity.
Where Mexico develops process technology, controls vendors or bears unreimbursed failures, different remuneration may be needed. The agreement title does not limit observed functions.
Limited-risk distributor
The entity usually buys and resells products with bounded commercial functions and risks. Review who sets pricing, approves discounts, selects customers, manages marketing, holds inventory, extends credit and handles warranties.
“Limited” does not mean risk free or guaranteed margin in every circumstance. Define ordinary and exceptional risks and the adjustment mechanism. A target range needs an operating policy.
Decision-based functional analysis
Do not ask only who “does marketing” or “manages inventory.” Identify decisions over budget, campaign, vendor, stock level, destruction, discount, credit, capacity and contingencies. Record proposer, approver, executor and economic consequence.
Interviews should use recent examples. Compare job descriptions with emails, system rights, minutes and approvals.
Risk control
For market, inventory, credit, warranty, capacity, quality, product and change risk, identify decision, information and person. The assigned entity needs capability to control and fund outcomes.
A checked box does not prove control. If the foreign principal receives reports after Mexico decides in real time, the agreement may not reflect operations.
Financial capacity
An entity assuming risk should bear it financially. Analyze capital, liquidity, funding access and magnitude. Implicit group support does not replace the test.
If losses exceed capacity and another entity automatically funds them, determine whether the behavior reflects debt, equity or pricing. Financing conduct can reveal the actual risk bearer.
Assets and intangibles
Identify machinery, inventory, systems, customer lists, know-how, improvements, tooling and data. Legal title and economic use can differ. A plant may develop valuable knowledge without a patent.
DEMPE functions and unique property affect method and return. Do not place every local process inside a routine markup without analysis.
Agreements and conduct
Compare ownership, risk, price, adjustment, warranty, termination and authority clauses with facts. Mark consistency, deviation and evidence. Recurring deviations require changed operation or agreement.
A retroactive document does not alter past conduct. Record actual facts for prior periods and implement prospective responsibilities through people and systems.
Transfer pricing method
Method selection follows delineation. Cost plus or TNMM may suit routine manufacturing; resale price or TNMM may suit distribution; unique contributions can call for another method. No label mandates one.
The tested party and indicator depend on information and comparability. Mexico is not automatically tested.
Cost base
For manufacturing, define direct, indirect, depreciation, idle-capacity, pass-through, restructuring and nonrecurring cost. Account names do not decide inclusion. Reconcile with the ledger.
Markup on materials or tariffs may not reflect added value. Explain remunerated costs and pure recovery.
Distributor margin
Segment sales, product cost, marketing, logistics, warranty and credit. Operating margin should match model and period. Products, channels or regions may need separation.
Do not mix services, royalties and uncontrolled dealings into total profitability. Define segmentation before knowing results.
Request an Operating Model Validation to compare the label with agreements, decisions, risks and outcomes before close.
Losses and deviations
A loss does not automatically invalidate the model. Identify cause, control, period and comparables. Launch, market or capacity may explain deviation, but loss follows the entity controlling the risk.
When a limited entity repeatedly loses, review policy, adjustments and conduct. Repeated true-ups can mask an operationally broken model.
Year-end adjustments
Define range, point, formula, timing, CFDI invoicing, accounting and tax. The adjustment follows the agreement and economic cause. Monthly monitoring acts before filing.
Do not convert every deviation into an invoice. Determine ownership of the risk and whether the adjustment is real or virtual.
Idle capacity
Separate ordinary, extraordinary, structural and principal- or plant-driven idle capacity. Identify who approved investment and volume. Comparables may operate at other utilization levels.
Including all idle cost in a marked-up base may reward inefficiency an independent principal would reject.
Inventory and obsolescence
Legal ownership alone does not determine risk. Identify who forecasts, purchases, sets levels, approves discount and destroys goods. Systems and approvals are evidence.
If the distributor follows instructions and cannot mitigate, policy should reflect that. Independent decision-making can justify more consequence.
Marketing and market development
Distinguish routine promotion, market development and strategy. Budget, brand control, campaigns, data and horizon matter. Spending above comparable levels can create a contribution requiring analysis.
A limited distributor should not indefinitely fund investments controlled by the brand owner without clear policy.
Warranty and quality
Map design, manufacture, inspection, claim, provision and payment. A plant may control process quality while the principal controls product. A distributor may administer claims without bearing final cost.
Agreements, provisions and reimbursement should align. Persistent differences affect margin and risk.
People and systems
Organization charts should show functional reporting, authority and location. Systems reveal who can change price, vendor, inventory or credit. Access without authority and authority without capability are different.
Personnel moves without model updates can create a de facto restructuring. Review before changing contracts.
Monthly governance
The dashboard covers volume, price, cost, margin, inventory, credit, warranty, capacity and decisions. Every deviation has a cause, owner and action. Tax participates before close.
The committee reviews operations, not profitability alone. A margin within range does not compensate unpriced functions.
Implementation testing
Select decisions and trace request, approval and effect. Trace invoices and adjustments. Compare interviews with evidence. Test whether the assigned entity actually controls risk.
Perform 90- and 180-day reviews after changes. Document exceptions and remediation.
Remediation choices
If facts contradict the label, the group can change conduct, change characterization or both. Conduct changes need authority matrices, system access, people, budget and escalation—not merely an amendment. Characterization changes require a new method, policy, contracts and potentially valuation of transferred rights.
Prioritize material risks and do not force every local decision abroad. An efficient model can leave execution in Mexico while preserving genuine strategic control elsewhere. The file should explain that boundary and test it periodically.
Minimum file
RACI for critical decisions
Build a RACI for pricing, discounts, customers, vendors, volume, capacity, inventory, credit, warranty, quality, product, marketing and investment. Distinguish execution responsibility, approval authority, consultation and information. Use roles or names and thresholds, not entities alone.
Test it with actual decisions. If systems authorize someone else or exceptions are always resolved locally, update the model. A document disconnected from workflows provides weak evidence of control.
Indicators consistent with characterization
KPIs should match what an entity controls. A routine plant can be measured on quality, efficiency and delivery, but should not answer for demand controlled by the principal. A limited distributor can manage commercial execution while the strategy owner answers for brand decisions.
Bonuses, budgets and evaluations are evidence. If local management is rewarded for independently maximizing price and share, conduct may contradict a purely executory mandate. Align objectives, authority and remuneration.
New products, markets and exceptions
The model needs a procedure for launch, tariff, interruption, recall, strategic customer or regulation. Define who decides, how it is funded and when policy is reviewed. Without a procedure, the local entity often absorbs the event by default.
Record each exception with period and treatment. A recurring event is no longer exceptional and may require a new benchmark, agreement or characterization.
Onboarding an entity
Before launch, confirm people, systems, capital, agreements, invoicing, pricing, data and calendar. Test one transaction from order through payment. The model should not activate merely upon signature.
An opening review validates balances, inventory, property, customers and transferred functions. Analyze restructuring compensation separately where relevant. After 90 days, compare conduct with design and correct access or responsibility.
Interviews that produce useful evidence
Ask about the last exception rather than ideal policy: who identified obsolete stock, approved a discount, rejected a vendor, ordered overtime or paid a warranty. Request the screen, email, ticket or minutes. Process interviews reveal contradictions across functions.
Record date, participant and documents. Do not force answers to align; investigate differences. Divergent legal and operating accounts may show that the agreement no longer describes the business.
CFO and board review
The CFO should receive a margin bridge, risks, adjustments, cash and scenarios. The board reviews material model changes, unique functions, losses and restructurings. Approval identifies assumptions, owners and effective date.
Executive reporting should distinguish statistical compliance from operational alignment. Being within range is incomplete if another entity controls or contributes without remuneration.
Include agreements, FAR, risk matrix, charts, access rights, policies, benchmark, segmentation, cost base, adjustments, invoices, minutes and monitoring. Preserve versions.
The executive summary states proposed label, supporting facts, exceptions, remuneration and required change.
Illustrative example
A Mexican plant described as contractual selects vendors and process while the parent sets volume and owns product. Validation separates control over capacity, quality and procurement; adjusts cost base and markup; rewards specific know-how; changes approvals; and creates monitoring. The label remains only for genuinely routine functions.
Warning signs
Warnings include generic agreements, persistent losses, late adjustments, ownerless risks, ignored local decisions, unreconciled bases, distributor-funded marketing, principal-driven idle capacity charged to the plant and conflicting systems. Method chosen from label is another.
These signs indicate characterization may not survive facts.
Conclusion
A useful label summarizes an analyzed transaction; it does not create one. A defensible model aligns rights, people, decisions, risks, property, method and result.
Continuous validation prevents contract and business from separating and enables correction before audit or accumulated loss.
Request an Operating Model Validation to test whether characterization and remuneration survive actual conduct.
Verified official sources
- Mexican Chamber of Deputies, current Income Tax Law, Articles 179 and 180.
- OECD, Transfer Pricing Guidelines 2022, Chapters I–III and IX as relevant.
- SAT, tax treaties and related matters, as applicable.
Verification closed on August 2, 2026. Conclusions depend on facts, period and the applicable framework.